- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02266641
Parental One-carbon Folate and Choline Nutrition Modulates Risk of Off-spring Cancer Development: Human Cohort Study
January 30, 2018 updated by: National Taiwan University Hospital
Parental one-carbon nutrient intake (folic acid and choline) and the genetic polymorphisms of one-carbon metabolic enzyme were interact with regulating embryonic one-carbon metabolic environment, affect fetal DNA and RNA biosynthesis and methyl modification of the genome molecule, to promote the individual nutrient growth factor of growth and development.
Inadequate maternal one-carbon nutrient intake combined with genetic polymorphisms of one-carbon enzymatic mutation, causing one-carbon malnutrition, change fetal methyl metabolic nutrition environment.
It not only leads to fetal growth mutation - such as folate and choline deficiency, increasing the risk of fetal neural tube defect but also induce abnormal modifying of fetuses's post-genomic methylation markers, may alter imprinted genes function of progenitors, recompile threshold sensitivity or domain in regulation of metabolic reactions of offspring, resulting in long-lasting effect, increasing the risk of chronic diseases of offspring such as cancer.
According to the National Nutrition Survey results show that a considerable proportion of the Taiwanese people had poor one-carbon nutritional status.
48% of women intake 66% below the recommended intake reference value of folate.
Whether inadequate parental one-carbon nutrients intake combined with genetic polymorphisms of one-carbon enzymatic mutation will cause one-carbon malnutrition of fetus, affecting fetal growth and modifying the risk of cancer development relationship of offspring.
It is due to the lack of local ethnic data and empirical scientific reference at home and abroad, so it can not plan an effective maternal and children nutrient education and prevention strategies about methyl nutrition for early cancer prevention for Taiwanese.
Therefore, indigenous people is the intended population of study in this project, screening of healthy pregnant women with high risk factor for cancer and obese pregnant women, and detection of one-carbon nutrient intake and biochemical assessment of the nutritional status of the study group.
Supplying nutrition education intervention or multivitamin supplement to improve the poor nutritional status of persons.
Using related DNA methylation imprint marker about offspring growth and modifying development of cancer as assessment, this project explores the appropriate one-carbon nutrient intake in parents and children and the assessments in regulation of growth and reducing the cancer-related risk.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
118
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Taipei, Taiwan, 100
- National Taiwan University Hospital
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
21 years to 40 years (Adult)
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
Female
Description
Inclusion Criteria:
- Healthy pregnant women aged 21-40 years with first and single fetal pregnancy
- Healthy pregnant women aged 21-40 years with first and single fetal pregnancy and lineal relative had diabetes
- Healthy pregnant women aged 21-40 years with first and single fetal pregnancy and lineal relative had cancer
- Healthy pregnant women, who are overweight/obesity (pre-pregnancy BMI≧24 kg/m2) or her lineal relative with overweight/obesity, aged 21-40 years with first and single fetal pregnancy.
Exclusion Criteria:
- Pregnant women who had heart disease, kidney disease, cancer or accepting medical treatment
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Diagnostic
- Allocation: Non-Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Active Comparator: healthy pregnant women
Supply nutrition counseling and multivitamin supplement to people with poor nutritional status
|
Pregnancy diet (include one-carbon nutrients)
|
Experimental: healthy pregnant women's lineal relative with cancer
Supply nutrition counseling and multivitamin supplement to people with poor nutritional status
|
Pregnancy diet (include one-carbon nutrients)
|
Experimental: pregnant women or lineal relative with overweight/obesity
Supply nutrition counseling and multivitamin supplement to people with poor nutritional status
|
Pregnancy diet (include one-carbon nutrients)
|
No Intervention: healthy pregnant women's lineal relative with diabetes
Supply nutrition counseling and multivitamin supplement to people with poor nutritional status
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Assessment of maternal one-carbon nutrient (folate, choline, betaine, Vitamine B12) intake at the first trimester visit of pregnancy
Time Frame: 7-10 weeks
|
Using semiquantitative food frequency questionnaires (FFQ) to calculate dietary intake of one-carbon nutrient
|
7-10 weeks
|
Assessment of maternal one-carbon nutrient (folate, choline, betaine, Vitamine B12) intake at the second trimester of pregnancy
Time Frame: 20-28 weeks
|
Using 24 hours dietary recall and dietary record to calculate dietary intake of one-carbon nutrient
|
20-28 weeks
|
Assessment of maternal one-carbon nutrient (folate, choline, betaine, Vitamine B12) intake at the third trimester of pregnancy
Time Frame: 36-37 weeks
|
Using 24 hours dietary recall and dietary record to calculate dietary intake of one-carbon nutrient
|
36-37 weeks
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Measure maternal blood and urine biochemistry (folate, choline, betaine, homocysteine, Vitamine B2, Vitamine B6, Vitamine B12, etc.)
Time Frame: 7-10 weeks
|
7-10 weeks
|
Measure maternal blood imprinted genes (sonic hedgehog, insulin-like growth factor 2, long interspersed nuclear element 1, etc.) DNA methylation status, DNA 8-Hydroxydeoxyguanosine (8-OHdG) and inflammatory markers (TNF-α, NF-κB, Interleukin, etc.)
Time Frame: 7-10 weeks
|
7-10 weeks
|
Measure maternal blood and urine biochemistry (folate, choline, betaine, homocysteine, Vitamine B2, Vitamine B6, Vitamine B12, etc.)
Time Frame: 24-28 weeks
|
24-28 weeks
|
Measure maternal blood imprinted genes (sonic hedgehog, insulin-like growth factor 2, long interspersed nuclear element 1, etc.) DNA methylation status, DNA 8-Hydroxydeoxyguanosine and inflammatory markers (TNF-α, NF-κB, Interleukin, etc.)
Time Frame: 24-28 weeks
|
24-28 weeks
|
Measure maternal blood, cord blood and urine biochemistry (folate, choline, betaine, homocysteine, Vitamine B2, Vitamine B6, Vitamine B12, etc.)
Time Frame: 37-40 weeks
|
37-40 weeks
|
Measure maternal and cord blood and placenta tissues MTHFR C677T genotypes
Time Frame: 37-40 weeks
|
37-40 weeks
|
Measure maternal blood imprinted genes (sonic hedgehog, insulin-like growth factor 2, long interspersed nuclear element 1, etc.) DNA methylation status, DNA 8-Hydroxydeoxyguanosine (8-OHdG) and inflammatory markers (TNF-α, NF-κB, Interleukin, etc.)
Time Frame: 37-40 weeks
|
37-40 weeks
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Investigators
- Principal Investigator: Chien-Nan Lee, National Taiwan University Hospital
- Principal Investigator: Kuang-Ta Huang, Hueishin women and children clinic
- Principal Investigator: Chin-Pao Cheng, National Taiwan University Hospital
- Principal Investigator: Rwei-Fen S. Huang, Fu Jen Catholic University
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
October 1, 2014
Primary Completion (Actual)
December 1, 2017
Study Completion (Actual)
December 1, 2017
Study Registration Dates
First Submitted
October 13, 2014
First Submitted That Met QC Criteria
October 13, 2014
First Posted (Estimate)
October 17, 2014
Study Record Updates
Last Update Posted (Actual)
February 1, 2018
Last Update Submitted That Met QC Criteria
January 30, 2018
Last Verified
May 1, 2017
More Information
Terms related to this study
Other Study ID Numbers
- 201401034RINB
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Off-spring Cancer Risk
-
Morehouse School of MedicineRecruiting
-
New Mexico Cancer Care AllianceOhio State University Comprehensive Cancer Center; H. Lee Moffitt Cancer Center...RecruitingCancer | Cancer RiskUnited States
-
Prisma Health-UpstateRecruiting
-
University of Colorado, DenverRecruitingCancer RiskUnited States
-
St. Jude Children's Research HospitalNational Institute of Nursing Research (NINR)CompletedCancer | Cardiovascular RiskUnited States
-
University of Texas Southwestern Medical CenterCompletedHigh-Risk Cancer
-
University of UtahNew York UniversityEnrolling by invitationCancer | Risk Reduction BehaviorUnited States
-
St. Jude Children's Research HospitalUniversity of MinnesotaCompletedCardiovascular Risk | Pediatric CancerUnited States
-
University of Southern CaliforniaNational Cancer Institute (NCI)Recruiting
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI); National Institutes of Health (NIH)UnknownCancer | Risk Factors in LatinosUnited States
Clinical Trials on nutrition counseling
-
University of Alabama at BirminghamCompletedHead and Neck Cancer | Laryngeal Cancer | Pharyngeal CancerUnited States
-
University of CalgaryCompleted
-
University of Alabama at BirminghamAmerican Institute for Cancer ResearchCompletedHead and Neck Cancer | Laryngeal Cancer | Pharyngeal CancerUnited States
-
University of Alabama, TuscaloosaAcademy of Nutrition and DieteticsRecruitingBrain InjuriesUnited States
-
Harokopio UniversityState Scholarships Foundation, Athens, GreeceCompletedRheumatoid ArthritisGreece
-
Persephone BiosciencesKroger HealthRecruitingImpact of Dietary Chages Directed by Medical Nutrition Therapy on Gut Microbiome CompositionUnited States
-
Taipei Medical UniversityCompletedCerebrovascular DiseaseTaiwan
-
Orotta College of Medicine and Health SciencesCompletedPregnancy Nutritional DiseaseEritrea
-
Ege UniversityCompletedMalnutrition | Stroke, Acute | Old Age; DebilityTurkey
-
Wageningen UniversityCompleted